Translate

Saturday, September 28, 2019

FDA: OVER 6,000 DEAD FROM PUBERTY BLOCKING DRUG FOR TRANSGENDER CHILDREN~ENDOCRINOLOGIST DISPROVES HORMONAL, SURGICAL INTERVENTONS

MULTIPLICITY OF GENDERS DENIED & DISPROVED BY BIBLE BELIEVING DOCTOR

Medical Risks of Hormonal and Surgical Interventions for Gender Dysphoric Children

Michael K. Laidlaw, MD, is an Endocrinologist practicing in Rocklin, CA. Dr. Laidlaw graduated from University of Southern California School of Medicine in 2001 and has been in practice for 18 years. He explained the dangers of radical new transition-affirming therapies for children with gender dysphoria. Watch the full event here: https://www.youtube.com/watch?v=bnP_W...

Doctor Exposes Transgender Propaganda

 "Medical Harms from the Treatment of Child and Adolescent Gender Dysphoria"


FDA: OVER 6,000 DEAD FROM PUBERTY BLOCKING DRUG FOR TRANSGENDER CHILDREN

Parents of kids with gender dysphoria not warned about dangers of hormone blockers

BY KELEN MCBREEN
republished below in full unedited for informational, educational and research purposes:
A drug used to block puberty in children with gender dysphoria is responsible for the death of over 6,300 people, according to the Food & Drug Administration (FDA).
The Christian Post reports Leuprolide Acetate (Lupron) “is being prescribed off-label for use in children who have been diagnosed with gender dysphoria despite the lack of formal FDA approval for that purpose.”
“The drug is clinically approved for treatment of precocious puberty, a condition where children start their pubertal processes at an abnormally early age and the blocker is administered for a short time until the proper age,” the outlet continues.
Citing FDA data, the article reads, “Between 2012 and June 30 of this year, the FDA documented over 40,764 adverse reactions suffered by patients who took Leuprolide Acetate (Lupron), which is used as a hormone blocker. More than 25,500 reactions logged from 2014-2019 were considered ‘serious,’ including 6,370 deaths.”
A California-based endocrinologist named Michael Laidlaw has been exposing the controversial tactic of prescribing testosterone to girls as young as 8 who suffer from gender dysphoria.
Laidlaw argues, “Gender dysphoria is not an endocrine condition, but is a psychological one and should, therefore, be treated with proper psychological care.”
However, when puberty blockers are given to children, an endocrine condition is created.
This dangerous practice is becoming increasingly lucrative for Big Pharma company AbbVie, with Lupron sales in the United States hitting $669 million in 2017.

_____________________________________________________________
SEE ALSO:
THE TERRIBLE FRAUD OF TRANSGENDER MEDICINE
At the Teens4Truth Conference, Ft. Worth, TX, Nov. 18, 2017. A physician who was in the 
Johns Hopkins Univ. Hospital group where "transgender medicine" was developed describes 
the lies, bad medicine, and fraud behind that movement. Quentin Van Meter, MD, FCP is a 
pediatric endocrinologist. He is a Fellow of the American College of Pediatricians and the 
American Association of Clinical Endocrinologists.